Ceredex Value Advisors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-101,420
Closed -$7.01M 159
2023
Q3
$7.01M Sell
101,420
-51,373
-34% -$3.67M 0.12% 137
2023
Q2
$11.1M Sell
152,793
-24,000
-14% -$1.62M 0.18% 127
2023
Q1
$12.7M Sell
176,793
-10,537
-6% -$807K 0.2% 113
2022
Q4
$14M Sell
187,330
-19,110
-9% -$1.37M 0.22% 108
2022
Q3
$13.5M Sell
206,440
-4,200
-2% -$322K 0.22% 91
2022
Q2
$14.8M Sell
210,640
-26,612
-11% -$2.14M 0.22% 88
2022
Q1
$21.8M Sell
237,252
-23,700
-9% -$2.23M 0.26% 93
2021
Q4
$26.4M Buy
260,952
+29,023
+13% +$2.96M 0.29% 88
2021
Q3
$22.6M Buy
231,929
+33,629
+17% +$3.39M 0.26% 93
2021
Q2
$20.5M Buy
+198,300
New +$20.2M 0.23% 98

Other funds holding CRI

Ceredex Value Advisors's CRI Position: Q4 2023 in Review

Ceredex Value Advisors sold out of Carter's (CRI) in Q4 2023, closing a stake of 101,420 shares — an estimated $7.01M sold.

Ceredex Value Advisors first reported a position in CRI in Q2 2021 and held it in 10 quarters. The position peaked at $26.4M in Q4 2021. 320 funds tracked by Wall St. Rank hold CRI as of Q4 2023.

  • Ceredex Value Advisors reported no remaining Carter's position as of Q4 2023 after selling out during the quarter.
  • Ceredex Value Advisors sold 101,420 Carter's shares in Q4 2023, an estimated $7.01M.
  • Ceredex Value Advisors first reported a position in Carter's in Q2 2021 and held it in 10 quarters.
  • Ceredex Value Advisors's Carter's position peaked at $26.4M in Q4 2021.
  • 320 funds tracked by Wall St. Rank held Carter's as of Q4 2023.

Based on Ceredex Value Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.